| 12098148 |
Therapeutic compounds |
Emma Louise Blaney, Duncan J. Crick, Simon Ross Crumpler, Cathy Louise Lucas, Barrie Martin +9 more |
2024-09-24 |
|
| 11680068 |
Compounds useful as RET inhibitors |
Allan Jordan, Rebecca Newton, Jonathan Mark Sutton, Bohdan Waszkowycz |
2023-06-20 |
|
| 11661423 |
Heterocyclic compounds as RET kinase inhibitors |
Allan Jordan, Rebecca Newton, Bohdan Waszkowycz, Jonathan Mark Sutton, Silvia Paoletta +1 more |
2023-05-30 |
|
| 11649237 |
Substituted imidazo[1,5-a]pyrazines for IRE1 inhibition |
Richard M. Keenan, Bradley Backes, Dustin J. Maly, Charles H. Reynolds, Ben Whittaker +4 more |
2023-05-16 |
|
| 11548896 |
Heterocyclic compounds as RET kinase inhibitors |
Allan Jordan, Rebecca Newton, Bohdan Waszkowycz, Jonathan Mark Sutton, Silvia Paoletta +1 more |
2023-01-10 |
|
| 11352361 |
Compounds useful as RET inhibitors |
Allan Jordan, Rebecca Newton, Jonathan Mark Sutton, Bohdan Waszkowycz |
2022-06-07 |
|
| 11236084 |
Substituted azaindoline derivatives as NIK inhibitors |
Calum Macleod, Samuel Edward Mann, Janusz Jozef Kulagowski, Ian Stansfield, Olivier Alexis Georges Querolle +4 more |
2022-02-01 |
$286,578,000 |
| 11186589 |
Cyanoindoline derivatives as NIK inhibitors |
Ian Stansfield, Olivier Alexis Georges Querolle, Yannick Aime Eddy Ligny, Gerhard Max Gross, Edgar Jacoby +5 more |
2021-11-30 |
$200,682,000 |
| 11180487 |
Substituted cyanoindoline derivatives as NIK inhibitors |
Ian Stansfield, Olivier Alexis Georges Querolle, Virginie Sophie Poncelet, Gerhard Max Gross, Edgar Jacoby +5 more |
2021-11-23 |
$199,606,000 |
| 11136311 |
Heteroaromatic derivatives as NIK inhibitors |
Ian Stansfield, Olivier Alexis Georges Querolle, Yannick Aime Eddy Ligny, Gerhard Max Gross, Edgar Jacoby +5 more |
2021-10-05 |
$224,033,000 |
| 11001569 |
6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors |
Ian Stansfield, Olivier Alexis Georges Querolle, Gerhard Max Gross, Edgar Jacoby, Lieven Meerpoel +4 more |
2021-05-11 |
$134,025,000 |
| 10954241 |
Heterocyclic compounds as ret kinase inhibitors |
Allan Jordan, Rebecca Newton, Bohdan Waszkowycz, Jonathan Mark Sutton, Silvia Paoletta +1 more |
2021-03-23 |
|
| 10844067 |
Heterocyclic compounds as RET kinase inhibitors |
Allan Jordan, Rebecca Newton, Bohdan Waszkowycz, Jonathan Mark Sutton, Silvia Paoletta +1 more |
2020-11-24 |
|
| 10822342 |
Pyrazolopyrimidine derivatives as NIK inhibitors |
Patrizia Tisselli, Calum Macleod, Samuel Edward Mann, Terry Aaron Panchal, John Gary Montana +1 more |
2020-11-03 |
$160,690,000 |
| 10626089 |
Quinoline derivative in crystal form |
Donald John Daley, John Gary Montana, Mitsuru Teramoto, Takahiro Ito |
2020-04-21 |
|
| 10323045 |
Thienopyrimidine derivatives as NIK inhibitors |
Patrizia Tisselli, Calum Macleod, Samuel Edward Mann, John Gary Montana, Stephen Price |
2019-06-18 |
$111,100,000 |
| 10221180 |
Pyrazolopyrimidine derivatives as NIK inhibitors |
Patrizia Tisselli, Calum Macleod, Samuel Edward Mann, Terry Aaron Panchal, John Gary Montana +1 more |
2019-03-05 |
$272,142,000 |
| 10005776 |
Compounds as NIK inhibitors |
Patrizia Tisselli, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann, Stephen Price +1 more |
2018-06-26 |
$41,040,000 |
| 10005773 |
1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors |
Patrizia Tisselli, David Edward Clark, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann +3 more |
2018-06-26 |
$41,040,000 |
| 9981963 |
3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors |
Patrizia Tisselli, David Edward Clark, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann +3 more |
2018-05-29 |
$56,746,000 |
| 9981962 |
Pyrazole derivatives as NIK inhibitors |
Patrizia Tisselli, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann, John Gary Montana +2 more |
2018-05-29 |
$56,746,000 |
| 9643964 |
3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer |
Stephen Price, Janusz Jozef Kulagowski, Calum Macleod, Samuel Edward Mann, Terry Aaron Panchal +2 more |
2017-05-09 |
$139,713,000 |
| 9321736 |
Pyrimidine cyclohexyl glucocorticoid receptor modulators |
Robin Clark, Nicholas Charles Ray, Mohammad Sajad |
2016-04-26 |
$7,150,000 |
| 8906917 |
Pyrimidine cyclohexyl glucocorticoid receptor modulators |
Robin Clark, Nicholas Charles Ray, Mohammad Sajad |
2014-12-09 |
$7,387,000 |
| 8685973 |
Pyrimidine cyclohexyl glucocorticoid receptor modulators |
Robin Clark, Nicholas Charles Ray, Mohammad Sajad |
2014-04-01 |
$6,314,000 |
